Please login to the form below

Not currently logged in
Email:
Password:

Cuba

This page shows the latest Cuba news and features for those working in and with pharma, biotech and healthcare.

Tuberculosis: treatment and prevention

Tuberculosis: treatment and prevention

stage. These include DNA and dendritic cell vaccines among others. The Finlay Institute of Cuba is developing vaccines for the prevention of various bacterial, viral and parasitic diseases.

Latest news

  • Developing therapeutic cancer vaccines Developing therapeutic cancer vaccines

    One such vaccine is racotumomab, which is marketed as Vaxira in Argentina and Cuba for the treatment of late-stage NSCLC.

  • Are you number 12?

    2009 campaign increased the WHA's global reach, with activities in the following countries for the first time: Azerbaijan, Chile, Colombia, Cuba, Dominican Republic, Ghana, Greece, Israel, Jordan, Kuwait, Mauritius, Nigeria,

  • The Sea of Love

    PROTOPIC- for atopic dermatitis. I met an eel in Cuba on a recent diving trip.

  • Love him or hate him

    The good old NHS also makes an appearance, as Moore compares the US system to that in England, France, Canada and even Cuba, just to make sure any nervy American politicians

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    countries including Mexico, the Dominican Republic and Cuba. ... Excludes US. US. † Excludes China, Korea. †† 28 EU member states, Switzerland, Iceland, Norway, Lichtenstein, all LatAm countries including  Mexico, Dominican Republic and Cuba. ‡

  • Positive prospects for pharma in Latin America Positive prospects for pharma in Latin America

    Espicom Business Intelligence predicts that the region's eight major markets — Brazil, Mexico, Argentina, Chile, Colombia, Cuba, Peru and Venezuela — will represent a retail value of $80bn in 2013, up from

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics